10x Genomics Reaches $68 Million Patent Settlement With Bruker

MT Newswires Live
05-15

10x Genomics (TXG) said Wednesday it reached a settlement agreement with Bruker (BRKR) to resolve all worldwide patent litigation and disputes between the two companies.

As part of the deal, Bruker will pay $68 million to 10x Genomics in equal quarterly installments from Q3 of 2025 through Q2 of 2026, along with ongoing royalties on sales of its spatial biology products for the duration of the licensed patents, according to 10x Genomics.

Shares of 10x Genomics were up 1.5% in after-hours activity.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10